SCHEDULE: OrthoPediatrics Corp. Ownership Filing Update

Several entities associated with Millennium Management have updated their beneficial ownership filings for OrthoPediatrics Corp., reporting a combined 3.2% stake.

Summary

• Integrated Core Strategies (US) LLC, Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander have jointly filed a Schedule 13G.
• This filing indicates a combined beneficial ownership of 811,042 shares for Integrated Core Strategies (US) LLC and 816,830 shares for Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander.
• The reporting entities are all organized in Delaware, except for Israel A. Englander who is a U.S. citizen.
• The filing pertains to the Common Stock of OrthoPediatrics Corp., with CUSIP number 68752L100.
• The date of the event requiring this filing is June 30, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it primarily reports on ownership stakes and does not contain operational or financial performance data that would indicate a positive or negative sentiment towards the company's prospects.

Positives

• The filing confirms a significant institutional ownership stake in OrthoPediatrics Corp., indicating investor confidence.
• The joint filing agreement suggests coordinated management of these holdings.

Risks

• The filing does not contain specific forward-looking statements or risk factors related to OrthoPediatrics Corp.'s business operations.

Future Outlook

No specific future outlook or guidance for OrthoPediatrics Corp. is provided in this ownership filing.

Management Comments

• The filing includes a certification stating that the securities were not acquired or held for the purpose of influencing control of the issuer, nor in connection with any transaction having that effect, other than in connection with a nomination under Rule 240.14a-11.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors exceeding a 5% ownership threshold, or for those who have acquired shares without the intent to influence control. The coordinated filing by entities associated with Millennium Management suggests a significant, albeit passive, investment in the medical device sector, specifically in pediatric orthopedics.

Stakeholder Impact

• Shareholders: The filing provides transparency regarding significant institutional ownership, which can influence market perception and potential future trading activity.
• Management of OrthoPediatrics Corp.: Awareness of substantial passive ownership by large investment firms is important for strategic planning.

Next Steps

• The reporting persons will continue to monitor their beneficial ownership of OrthoPediatrics Corp. stock.

Key Dates

Keywords

OrthoPediatrics Corp., Schedule 13G, Beneficial Ownership, Millennium Management, Integrated Core Strategies, SEC Filing, Investment, Equity